Esmeralda Herrero BSc. PhD


Esmeralda Herrero graduated from University College Dublin (UCD) with a BSc in Pharmacology and completed a PhD in Microbiology in University College Dublin. Her research investigated bacterial proteases and their role in prion decontamination and was filed into a UK patent in 2015. Following her PhD, Esmeralda worked for a year as research and development scientist for a novel biotech company before her role as scientific officer in virology in airmid healthgroup.

Esmeralda has over 5 years research experience in mammalian cell culture, molecular biology, bacterial culturing, infectious assays, protein purification, protein biochemistry and laboratory management


Tristan Russell BSc. PhD


Tristan graduated from the University of Leeds with a BSc in Microbiology. During his degree, Tristan completed a one-year internship at a pharmaceutical company where he gained experience of working in an industrial laboratory. Tristan moved to Ireland in 2014 after choosing to study for a PhD at University College Dublin. The PhD research used molecular biology techniques to study infectious disease, specifically host-virus interactions. Tristan recently graduated from his PhD and joined the virology team at airmid healthgroup in the spring of 2019.  


Kevin Ellison


Kevin is in his third year at DCU where he has been studying Genetics and Cell biology. He is working in the Environmental Chambers under the supervision of Jake Behan.


BS ISO 22196:2011


Measurement of antibacterial activity on plastics and other non-porous surfaces

Products that can be tested
Plastics and other non-porous surfaces including paint films that have antimicrobial treatments that are not light-activated

Description of Test

  • A quantified bacterial suspension is introduced to the treated and untreated surfaces
  • Following a period of incubation viable colony forming units are enumerated on an appropriate agar
  • The efficacy of the antibacterial finish is quantified following calculations relating to the satisfaction of the criteria for a valid test as outlined in the standard
  • The test method uses Escherichia coli or Staphylococcus aureus, however this can be adapted to include other bacterial (or fungal) species as requested by the client

Third Party Validation
On passing this test, the product can be labelled as having been tested by airmid healthgroup to BS ISO 22196:2011 in support of any claim relating to the test and data received

Turnaround Time
4 weeks from receipt of samples



The quality of the third party data we received from airmid healthgroup helped us showcase our innovative strategy of licensing this novel technology at a prestigious international scientific event, the European Innovation Convention. Ultimately this will allow us add value and differentiate our customer offerings through a focus on health and indoor air quality.
Mr. Robert Hickson, MD of VitrA Ireland